Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02678039 · ClinicalTrials.gov registry record · NA

Fluoroscopy-guided Versus Traditional Placement of Epidural Catheters

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT02678039: Completed NA study, sponsored by Dartmouth-Hitchcock Medical Center.

NCT02678039 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02678039, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

This is a prospective, randomized, controlled, and single blinded study. All work performed at Dartmouth-Hitchcock Medical Center, a tertiary care and level one trauma center for the state of New Hampshire with 28 operative suites. 100 patients scheduled to undergo thoracotomies are randomized to receive an epidural placed (for postoperative pain control) using either a traditional approach by feeling the spine for landmarks or using fluoroscopic X-ray guidance. Randomization is blinded to both the anesthesia team caring for the patient in the operating room and to one member of the acute pain team who follows the patient after surgery and is responsible for evaluating post operative pain control (dermatomal distribution of sensory blockade and visual analog scale) and pulmonary function (incentive spirometer use). All patients receive a standardized epidural infusion with local anesthetic and additional pain medications as needed.

Primary Outcome

Outcome measure is mg of morphine equivalent used in first 24 hours after surgery: Postoperative pain medication use during the first 24 postoperative hours will be calculated by converting medication to an equivalent amount of morphine. This is an indirect measure of postoperative pain.

Interventions

  • DEVICE Fluoroscopy
  • PROCEDURE Traditional

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2012-08
Est. Completion 2014-05
Phase NA
Dartmouth-Hitchcock Medical Center

427 total trials

What the finished NCT02678039 record still lists

NCT02678039 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Fluoroscopy is the first listed.

NCT02678039 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02678039 about?

NCT02678039 is a clinical study titled "Fluoroscopy-guided Versus Traditional Placement of Epidural Catheters". This is a prospective, randomized, controlled, and single blinded study. All work performed at Dartmouth-Hitchcock Medical Center, a tertiary care and level one trauma center for the state of New Hampshire with 28 operative suites. 100 patients scheduled to undergo thoracotomies are randomized to re...

What is the current status of trial NCT02678039?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2012-08. Estimated completion is 2014-05.

What interventions are being tested in trial NCT02678039?

The interventions under investigation include: Fluoroscopy (DEVICE), Traditional (PROCEDURE).

Who is sponsoring clinical trial NCT02678039?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02678039's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02678039, the US trial registry maintained by the National Library of Medicine. NCT02678039 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.